Skip to content
← Full study record

NCT00352534 · OUTCOME

Event Free Survival Probability

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor · Source last updated 2026-06-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Probability
Interval / dispersion
95% Confidence Interval
Time frame
4 years

What was measured

Probability of no relapse, secondary malignancy, or death after 4 year in the study.

Analysis population: Eligible very low risk or standard risk patients

Groups in this outcome

Very Low Risk

Very Low Risk

Standard Risk, Stage I or II, With LOH

Standard Risk, Stage I or II, with LOH

Standard Risk, Stage III

Standard Risk, Stage III

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Very Low Risk116
Standard Risk, Stage I or II, With LOH32
Standard Risk, Stage III535

Reported measurements

Source class 1
Values in Probability · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Very Low Risk0.88Not reported0.790.98Not reported
Standard Risk, Stage I or II, With LOH0.87Not reported0.731.00Not reported
Standard Risk, Stage III0.88Not reported0.850.91Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.79
        upper Limit
        0.98
        value
        0.88
      2. group Id
        OG001
        lower Limit
        0.73
        upper Limit
        1.00
        value
        0.87
      3. group Id
        OG002
        lower Limit
        0.85
        upper Limit
        0.91
        value
        0.88
denoms
  1. counts
    1. group Id
      OG000
      value
      116
    2. group Id
      OG001
      value
      32
    3. group Id
      OG002
      value
      535
    units
    Participants
description
Probability of no relapse, secondary malignancy, or death after 4 year in the study.
dispersion Type
95% Confidence Interval
groups
  1. description
    Very Low Risk
    id
    OG000
    title
    Very Low Risk
  2. description
    Standard Risk, Stage I or II, with LOH
    id
    OG001
    title
    Standard Risk, Stage I or II, With LOH
  3. description
    Standard Risk, Stage III
    id
    OG002
    title
    Standard Risk, Stage III
param Type
NUMBER
population Description
Eligible very low risk or standard risk patients
reporting Status
POSTED
time Frame
4 years
title
Event Free Survival Probability
type
PRIMARY
unit Of Measure
Probability

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice